Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula

作者: Richard B. Freeman , Robert G. Gish , Ann Harper , Gary L. Davis , John Vierling

DOI: 10.1002/LT.20979

关键词:

摘要: Richard B. Freeman Jr., Robert G. Gish, Ann Harper, Gary L. Davis, John Vierling, Leslie Lieblein, Goran Klintmalm, Jamie Blazek, Hunter, and Jeffrey Punch Division of Transplantation, Department Surgery, Tufts–New England Medical Center, Boston, MA; Departments Medicine Transplantation the Hepatology Complex GI, Physicians Foundation, California Pacific San Francisco, CA; United Network for Organ Sharing, Richmond, VA; Baylor Regional Transplant Institute, University Dallas, TX; Medicine, David Geffen School at UCLA, Los Angeles, Ochsner Multi-Organ New Orleans, LA; Michigan, Arbor, MI

参考文章(27)
Jeffrey Punch, Robert G. Gish, Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors Liver Transplantation. ,vol. 12, pp. S122- S123 ,(2006) , 10.1002/LT.20970
Francis Y. Yao, Nathan M. Bass, Bev Nikolai, Timothy J. Davern, Robert Kerlan, Victor Wu, Nancy L. Ascher, John P. Roberts, Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transplantation. ,vol. 8, pp. 873- 883 ,(2002) , 10.1053/JLTS.2002.34923
Richard B. Freeman, Mortality risk versus other endpoints: who should come first on the liver transplant waiting list? Liver Transplantation. ,vol. 10, pp. 675- 677 ,(2004) , 10.1002/LT.20103
W. Kenneth Washburn, Robert G. Gish, Patrick S. Kamath, Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome Liver Transplantation. ,vol. 12, pp. S93- S94 ,(2006) , 10.1002/LT.20964
W. Kenneth Washburn, Robert G. Gish, Model for end-stage liver disease (MELD) exception for severe pruritus Liver Transplantation. ,vol. 12, pp. S119- S119 ,(2006) , 10.1002/LT.20976
Michael J. Krowka, Michael B. Fallon, David C. Mulligan, Robert G. Gish, Model for end-stage liver disease (MELD) exception for portopulmonary hypertension Liver Transplantation. ,vol. 12, pp. S114- S116 ,(2006) , 10.1002/LT.20975
Simon Horslen, Stuart Sweet, Robert G. Gish, Ross Shepherd, Model for end-stage liver disease (MELD) exception for cystic fibrosis Liver Transplantation. ,vol. 12, pp. S98- S99 ,(2006) , 10.1002/LT.20967
Scott W. Biggins, Harry J. Rodriguez, Peter Bacchetti, Nathan M. Bass, John P. Roberts, Norah A. Terrault, Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology. ,vol. 41, pp. 32- 39 ,(2005) , 10.1002/HEP.20517
Patricia Sheiner, Robert G. Gish, Arun Sanyal, Model for end-stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding Liver Transplantation. ,vol. 12, pp. S112- S113 ,(2006) , 10.1002/LT.20969
Richard B Freeman Jr, Russell H Wiesner, Ann Harper, Sue V McDiarmid, Jack Lake, Erick Edwards, Robert Merion, Robert Wolfe, Jeremiah Turcotte, Lewis Teperman, The new liver allocation system: Moving toward evidence‐based transplantation policy Liver Transplantation. ,vol. 8, pp. 851- 858 ,(2002) , 10.1053/JLTS.2002.35927